CPNG Form 4: Gaurav Anand disposes 75,350 shares under 10b5-1 plan

Rhea-AI Filing Summary

Coupang's Chief Financial Officer, Gaurav Anand, reported the sale of 75,350 shares of Class A common stock on 08/11/2025 at a weighted average price of $27.7877 per share under a Rule 10b5-1 trading plan adopted on December 8, 2024 to satisfy tax obligations. The filing states the shares were sold in multiple transactions at prices ranging from $27.65 to $28.02. After the reported sale, Mr. Anand beneficially owns 2,016,940 shares directly; an additional 150,000 shares are held of record by the Gaurav Anand 2021 Trust, for which his spouse serves as trustee. The report was signed by an attorney-in-fact.

Positive

• Sale executed under a Rule 10b5-1 trading plan adopted December 8, 2024, indicating a preplanned transaction
• Substantial post-sale holdings remain: 2,016,940 shares directly and 150,000 shares indirectly via the Gaurav Anand 2021 Trust

Negative

• Disposition of 75,350 Class A shares on 08/11/2025 at a weighted average price of $27.7877
• Shares were sold in multiple transactions at prices ranging from $27.65 to $28.02

Insights

Financial Analyst

TL;DR: Sale was executed under a pre-established 10b5-1 plan and leaves the CFO with substantial post-sale holdings; market impact likely limited.

The filing shows a planned disposition of 75,350 Class A shares on 08/11/2025 at a weighted average price of $27.7877, executed under a Rule 10b5-1 plan adopted 12/08/2024 to satisfy tax obligations. Post-sale direct beneficial ownership is 2,016,940 shares with an additional 150,000 held indirectly in a trust. The sale size is modest relative to total post-sale beneficial ownership (~2.17M shares), suggesting limited immediate dilution or governance change.

Corporate Governance Expert

TL;DR: The use of a documented 10b5-1 plan and trust disclosures improves transparency, reducing concerns about opportunistic insider trading.

The Form 4 discloses that the transactions were effected pursuant to a Rule 10b5-1 plan adopted on December 8, 2024 and provides the trust disclosure (Gaurav Anand 2021 Trust, spouse as trustee). The filing notes the transaction range and weighted average sale price and includes an attorney-in-fact signature, which are standard governance disclosures that allow investors and regulators to verify adherence to pre-planned trading arrangements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anand Gaurav

(Last) (First) (Middle)

C/O COUPANG, INC.

720 OLIVE WAY, SUITE 600

(Street)

SEATTLE WA 98101

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Coupang, Inc. [ CPNG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/11/2025		S		75,350(1)	D	$27.7877(2)	2,016,940	D
Class A Common Stock								150,000	I	See Footnote(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2024, which was entered into primarily to satisfy certain tax obligations.

2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $ 27.65 to $28.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The shares are held of record by the Gaurav Anand 2021 Trust, for which the Reporting Person's spouse serves as the trustee.

Remarks:

	/s/ Ruby Alexander, Attorney-in-Fact for Gaurav Anand	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Coupang (CPNG) CFO Gaurav Anand sell?

75,350 Class A shares sold on 08/11/2025 under a Rule 10b5-1 plan at a weighted average price of $27.7877 per share.

How many Coupang shares does Gaurav Anand own after the sale?

He beneficially owns 2,016,940 shares directly and there are 150,000 shares held of record by the Gaurav Anand 2021 Trust (spouse is trustee).

Why were the shares sold under this Form 4?

The sales were effected pursuant to a Rule 10b5-1 trading plan adopted 12/08/2024, which the filing states was entered into primarily to satisfy tax obligations.

What price range did the sale occur at?

The filing reports sales at prices ranging from $27.65 to $28.02 per share, with a reported weighted average of $27.7877.

Who signed the Form 4 for Gaurav Anand?

The form was signed by Ruby Alexander, Attorney-in-Fact for Gaurav Anand.